Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02847975 · ClinicalTrials.gov registry record · Phase 1

Sodium Nitrate to Improve Blood Flow

A Phase 1 study of Becker Muscular Dystrophy, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
Phase 1
Development phase
11
Enrollment target
2
Study locations

NCT02847975 is a Phase 1 study of Becker Muscular Dystrophy that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 11 participants, below the 1,395-participant average among 12 other Becker Muscular Dystrophy trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02847975, a Phase 1 study of Becker Muscular Dystrophy, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
11 participants
Enrollment target
2
Study locations

Study Summary

Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium nitrite- which is an indirect nitric oxide donor.

Conditions Studied

Becker Muscular Dystrophy

Interventions

  • DIETARY_SUPPLEMENT Sodium nitrate

Study Locations (2)

California

  • Cedars-Sinai Heart Institute - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2013-10
Est. Completion 2014-12
Phase Phase 1

Sponsor

Cedars-Sinai Medical Center

339 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02847975

The ClinicalTrials.gov registry entry for NCT02847975 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,395-participant average among 12 other Becker Muscular Dystrophy trials with a reported enrollment target (99% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Becker Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Sodium nitrate is the first listed.

NCT02847975 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02847975 about?

NCT02847975 is a clinical study titled "Sodium Nitrate to Improve Blood Flow". Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium ni...

What is the current status of trial NCT02847975?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2013-10. Estimated completion is 2014-12.

What conditions does trial NCT02847975 study?

This clinical trial studies the following conditions: Becker Muscular Dystrophy.

What interventions are being tested in trial NCT02847975?

The interventions under investigation include: Sodium nitrate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02847975?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02847975 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Becker Muscular Dystrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Becker Muscular Dystrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.